Home›Stocks›DKL

DKL — structural market context

DELEK LOGISTICS PARTNERS, LP

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 15. Each line shows the earlier value, the later value and their dates.

Price

Close $55.94 (Oct 15) vs $56.41 (Oct 14): −0.83%.

Volume

0.45× its 20-session average (195K) on Oct 15.

Includes pre- and post-market trading.

Short interest

Short interest 405K shares (settlement Sep 30) vs 274K (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 1–Sep 14, published Sep 30): 1 day with fails, largest 3K shares on Sep 4.

Previous file (settlements Aug 17–Aug 31, published Sep 16): 1 day with fails, largest 5K shares on Aug 19.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

DKL short interest & days to cover

SHARES SHORT
405K
% OF FLOAT
—
DAYS TO COVER
1.4
CHANGE VS PRIOR
+48.0%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (16d ago)

DKL fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-04 · 42d3K$55.27
2026-08-19 · 58d5K$53.74
2026-08-14 · 63d123K$52.3

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

DKL insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 0 sales · 5 filings not counted

InsiderTypeSharesValueFiled
Hobbs Mark Wayne · officer: EVPBuy (P)4K—*2026-08-17
Soreq Avigal · director, officer: PresidentBuy (P)3K—*2026-08-17
Spiegel Reuven · director, officer: Executive Vice President, DKLBuy (P)1K—*2026-08-17
Wright Robert G. · officer: EVP, Chief Financial OfficerBuy (P)2K—*2026-08-17
Yemin Ezra Uzi · director, officer: ChairmanBuy (P)6K—*2026-08-17

*Value not shown: the filed price could not be checked against the U.S. listing.

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

DKL analyst ratings

FirmActionRatingPublished
UBSholdNeutral2026-09-21
UBSprice_target—2026-09-21

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

Are insiders buying DKL?
In the last 12 months of SEC Form 4 filings, DKL recorded 0 insider purchases and 0 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). 5 filings not counted: the filed price could not be checked against the U.S. listing. These are attributed public records — information, not instruction.
What do analysts say about DKL?
The most recent action: UBS hold to Neutral on 2026-09-21. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell DKL?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with D

DAR · DARLING INGREDIENTS INC.DASH · DoorDash, Inc.DDOG · Datadog, Inc.DFH · Dream Finders Homes, Inc.DFTX · Definium Therapeutics, Inc. CoDGICA · Donegal Group, Inc.All D →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.